Pharmafile Logo

Point of Difference

Point of Difference was formed in 2004 with a clear focus on the selection, assessment and development of leaders and managers. Our belief is that at key points in both life and business, the right decision can have long-reaching implications for success and fulfilment. Our aim is to be there at those points of difference to help challenge and shape thinking.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

Company Details

43 The Croft, Haddenham, Aylesbury, Bucks, HP17 8AS, United Kingdom
+44 (0)7851 744 508

 Latest Content from PMHub 

Listening and hearing – how patients’ online behaviour can help us to improve wellbeing in psoriasis.

White Papers and Resources | October 29, 2023 | Mednet

The following article was developed using information gathered through primary and secondary desk research, including a recent Social Listening project conducted by our team at Mednet.

Create Long-lasting KOL Relationships, benefits of virtual advisory boards

Here's another top reason why virtual advisory boards are simply better than in-person and hybrid advisory boards. #4. More Frequent Interactions and Long-lasting KOL Relationships Another important benefit of online...

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Press Releases | October 23, 2023 | OPEN Health

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Infographic: Rare Diseases in China

White Papers and Resources | October 23, 2023 | Inizio

How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.